Journal of Crohns & Colitis

期刊官网投稿通道

提出问题

友情提示：以下期刊信息可能会有更新，仅供参考，请在投稿前自行登录期刊官网仔细核实。

期刊名

Journal of Crohns & Colitis

J CROHNS COLITIS

ISSN / eISSN

1873-9946

目标和范围

Journal of Crohn's and Colitis is concerned with the dissemination of knowledge on clinical, basic science and innovative methods related to inflammatory bowel diseases. The journal publishes original articles, review papers, editorials, leading articles, viewpoints, case reports, innovative methods and letters to the editor.

研究方向

胃肠肝病学

CiteScore

13.90

查看趋势图

CiteScore 学科排名

类别	分区	排名
Medicine - General Medicine	Q1	#35/830

Web of Science 核心合集

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

类别 (Journal Citation Reports 2023)	分区
GASTROENTEROLOGY & HEPATOLOGY - SCIE	Q1

H-index

出版国家或地区

NETHERLANDS

出版商

Oxford University Press

出版周期

Quarterly

出版年份

2007

年文章数

190

Open Access

通讯方式

ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE

同领域相关热门期刊
近期发表文章

De-escalation of biological treatment in inflammatory bowel disease: A comprehensive review: (2023) Javier P Gisbert, María Chaparro

Initial management of intraabdominal abscesses and preventive strategies for abscess recurrence in penetrating Crohn’s disease: a national multicenter study based on ENEIDA registry: (2023) Diego Casas Deza, Cristina Polo Cuadro, Ruth de Francisco, Milagros Vela González, Fernando Bermejo, Ignacio Blanco, Álvaro de la Serna, Luis Bujanda,...

Differences in Management and Outcomes of Older and Younger Adults with Acute Severe Ulcerative Colitis: (2023) Taylor Boyd, Elizabeth Bonareri Araka, Bharati Kochar, Ashwin N Ananthakrishnan

Matrix metalloproteinases in intestinal fibrosis: (2023) Carin Biel, Klaas Nico Faber, Ruud A Bank, Peter Olinga

Ozanimod-Exposed Patients with Ulcerative Colitis Undergoing Total Colectomy Exhibit Unique Lymph Node Histologic Changes: (2023) Nathaniel A Cohen, Christopher R Weber, Jason X Cheng, David Choi, Nicole M Garcia, Natalie K Choi, David T Rubin

Frailty screening associates with hospitalization and decline in quality of life and functional status in older patients with inflammatory bowel disease: (2023) Vera E R Asscher, Mar D M Rodriguez Girondo, J Fens, Sanne N Waars, Rogier J L Stuyt, A Martine C Baven-Pronk, Nidhi Srivastava, Rutger J Jacobs, Jeof...

Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases (IBD): Real World Results from the International Organization for the study of IBD: (2023) Sophie Vieujean, James O Lindsay, Ferdinando D’Amico, Vineet Ahuja, Mark S Silverberg, Ajit Sood, Jesus K Yamamoto-Furusho, Masakazu Nagahori, Mamoru...

Janus kinase inhibitors differentially inhibit specific cytokine signals in the mesenteric lymph node cells of IBD patients: (2023) Duncan C Hindmarch, Sofya Malashanka, Donna M Shows, Astrid S Clarke, James D Lord

Does Kono-S Anastomosis Reduce Recurrence in Crohn’s Disease Compared with Conventional Ileocolonic Anastomosis? A Nationwide Propensity Score-matched Study from GETAID Chirurgie Group [KoCoRICCO Study]: (2023) Line Alibert, Louis Betton, Antoine Falcoz, Gilles Manceau, Stéphane Benoist, Philippe Zerbib, Juliette Podevin, Léon Maggiori, Antoine Brouquet, Gaël...

Lymphoma in Patients with Inflammatory Bowel Disease: A Multicentre Collaborative Study Between GETAID and LYSA: (2023) Marie Muller, Julien Broséus, Adrien Guilloteau, Stéphane Wasse, Catherine Thiéblemont, Stéphane Nancey, Guillaume Cadiot, Aurélien Amiot, David Lahar...

认证评论

注：认证评论选取于全球各个学术评论平台和社交媒体。

Leading journal in the field of enteritis. In the past, it mainly consisted of clinical papers, but gradually started to include some basic research. Due to the frequent publication of highly cited IBD guidelines, the impact factor is expected to stabilize at around 10 points in the future. Based on my submission experience, I feel that this journal treats Chinese researchers comparatively well and it is worth considering if there are good results.

2022-03-10

查看所有评论

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started